Invivyd (IVVD) Scheduled to Post Quarterly Earnings on Thursday

Invivyd (NASDAQ:IVVD) will announce its earnings results before the market opens on Thursday, November 14th. Analysts expect the company to announce earnings of ($0.32) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Invivyd (NASDAQ:IVVD) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.03). The business had revenue of $2.26 million during the quarter, compared to the consensus estimate of $4.91 million. On average, analysts expect Invivyd to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Invivyd Stock Performance

Shares of IVVD opened at $0.98 on Tuesday. The stock has a 50-day moving average of $0.99 and a two-hundred day moving average of $1.33. Invivyd has a one year low of $0.81 and a one year high of $5.20. The stock has a market cap of $116.75 million, a P/E ratio of -0.54 and a beta of 0.65.

Analyst Ratings Changes

Several brokerages recently weighed in on IVVD. EF Hutton Acquisition Co. I upgraded Invivyd to a “strong-buy” rating in a research note on Wednesday, October 30th. HC Wainwright restated a “buy” rating and issued a $15.00 price target on shares of Invivyd in a research note on Tuesday, October 29th.

Invivyd Company Profile

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.